IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 25,737 results that match your search.25,737 results
  • Relinquishing power: the UK has bowed to EU rulings The UK government will redeem its so-called golden shares in Britain's five biggest energy companies in the wake of a series of rulings by the European Court of Justice that the special share arrangements violate EU law.
  • Enron's attempts to unwind some of its derivative transactions could threaten the future of the capital markets, say derivatives specialists.
  • The United Arab Emirates (UAE) finalized the setting up of financial free zones, which are exempt from all federal and commercial laws within the UAE. The Dubai International Financial Centre, one of the new zones, has welcomed the development as it allows it to push ahead with creating its own set of financial laws based on international best practice without local law risks.
  • Banks must simplify deals to keep Hong Kong's retail investors hungry for structured notes. By Richard Mazzochi, Scott Farrell and Abigail Rath
  • Europe's member states will implement the Prospectus Directive within the next year. Here, Tim Morris, looks at the impact of the Directive on convertible and exchangeable bonds
  • Legislators across Asia must harmonize laws governing secured transactions and insolvency, say Ron Harmer and Michael Sloan
  • Europe's dithering over the equivalence of national accounting standards to IAS is forcing issuers to raise capital elsewhere, say Stephen Revell and David Cotton
  • A Delaware court ruling has put independent directors and the investment opportunities that come their way under closer judicial scrutiny. Marie Lona and Melissa Benzon explain how
  • The recent Norex ruling shows why companies cannot rely on US courts to try cases that have been rejected abroad. Owen Pell and William Spiegelberger explain
  • Aventis and Sanofi-Synthelabo are set to merge after a tense three-month standoff. But at what price? Megan Murphy looks at whether a regulatory decision could leave French companies more vulnerable to takeover